Survival of blacks and whites after a cancer diagnosis.

CONTEXT In recent years a theory that cancer biology is different in blacks and whites has gained prominence in reaction to epidemiologic observations that blacks have poorer survival than whites, even when diagnosed with cancer of similar severity. Yet, few studies have evaluated whether lower-quality treatment and shorter overall life expectancy due to a greater burden of other illnesses may explain the survival discrepancy. OBJECTIVE To estimate the magnitude of overall and cancer-specific survival differences between blacks and whites who receive comparable treatment for similar-stage cancer. DATA SOURCES We searched MEDLINE for English-language articles published from 1966 to January 2002 that reported on overall survival for black and white patients treated similarly for cancer. STUDY SELECTION The abstracts or titles for 891 citations were independently examined by 2 authors. The full text was retrieved if the abstract mentioned both black and white patients, made some comment regarding either similarity of treatment received or presented an analysis based on the treatment received, and commented on survival. Studies were included if they included data for at least 10 black and 10 white patients; specified the cohort ascertainment method and what measures were undertaken to minimize loss to follow-up; summarized survival of both blacks and whites using actuarial measures; presented outcomes within stage, adjusted for stage, or based on cohorts with balanced stage distributions; and specified that blacks and whites in the study received similar treatment. We identified 89 unique cohorts in 54 articles that met our inclusion criteria. DATA EXTRACTION Overall survival rates and hazard ratios (HRs) for death for blacks relative to whites were calculated. These were subsequently adjusted for rates of death due to causes other than the cancer under study to determine cancer-specific survival and cancer-specific HRs. DATA SYNTHESIS Results represent 189 877 white and 32 004 black patients with 14 different cancers. Compared with whites, blacks had an overall excess risk of death (HR, 1.16; 95% confidence interval [CI], 1.12-1.20). After correction for deaths due to other causes, the cancer-specific HR was 1.07 (95% CI, 1.02-1.13). Of the 14 cancers, blacks were at a significantly higher risk of cancer-specific death only for cancer of the breast, uterus, or bladder. CONCLUSIONS Only modest cancer-specific survival differences are evident for blacks and whites treated comparably for similar-stage cancer. Therefore, differences in cancer biology between racial groups are unlikely to be responsible for a substantial portion of the survival discrepancy. Differences in treatment, stage at presentation, and mortality from other diseases should represent the primary targets of research and interventions designed to reduce disparities in cancer outcomes.

[1]  C. Sutherland,et al.  Long‐term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes , 1986, Cancer.

[2]  David Collett.  Modelling Survival Data in Medical Research , 1994 .

[3]  P. Goodman,et al.  Leuprolide With and Without Flutamide in Advanced Prostate Cancer , 1990, Cancer.

[4]  C. Redmond,et al.  Determinants of black/white differences in colon cancer survival. , 1995, Journal of the National Cancer Institute.

[5]  D. Schultz,et al.  Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome , 1992, Cancer.

[6]  C. Wells,et al.  "Benign" tumors and "early detection" in mammography-screened patients of a natural cohort with breast cancer. , 2000, Archives of internal medicine.

[7]  Michael J. Symons,et al.  Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States) , 1999, Cancer Causes & Control.

[8]  D K Wagener,et al.  Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. , 2001, Journal of the National Cancer Institute.

[9]  S. Selvin,et al.  Black-white differences in stage-specific cancer survival: analysis of seven selected sites. , 1991, American journal of epidemiology.

[10]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[11]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[12]  C. Perez,et al.  Prognostic factors in inflammatory breast cancer. Univariate and multivariate analysis , 1989, Cancer.

[13]  I. Thompson,et al.  Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. , 1995, JAMA.

[14]  A. Pollack,et al.  Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation. , 1998, International journal of radiation oncology, biology, physics.

[15]  C. C. Johnson,et al.  Racial differences in surgically staged patients with endometrial cancer. , 1997, Journal of the National Medical Association.

[16]  I. Rubio,et al.  Racial differences in breast cancer survival: the effect of residual disease. , 2001, The Journal of surgical research.

[17]  S. Marcella,et al.  Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. , 2001, Journal of clinical epidemiology.

[18]  E. Franco,et al.  Race and gender influences on the survival of patients with mouth cancer. , 1993, Journal of clinical epidemiology.

[19]  W. Curran,et al.  Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer. , 1992, Journal of the National Cancer Institute.

[20]  C. Pettaway.  Racial differences in the androgen/androgen receptor pathway in prostate cancer. , 1999, Journal of the National Medical Association.

[21]  B. Smedley,et al.  The unequal burden of cancer : an assessment of NIH research and programs for ethnic minorities and the medically underserved , 1999 .

[22]  H. Weiss,et al.  Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  C. C. Johnson,et al.  Race and differences in breast cancer survival in a managed care population. , 1999, Journal of the National Cancer Institute.

[24]  J. Concato,et al.  Differences in cervical cancer mortality among black and white women. , 1999, Obstetrics and gynecology.

[25]  D. McClish,et al.  Differences in initial treatment patterns and outcomes of lung cancer in the elderly. , 1995, Lung cancer.

[26]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[27]  A. Whittemore,et al.  Race, prostate cancer survival, and membership in a large health maintenance organization. , 1998, Journal of the National Cancer Institute.

[28]  W. Page,et al.  Racial and socioeconomic factors in cancer survival. A comparison of veterans administration results with selected studies , 1980, Cancer.

[29]  C. Redmond,et al.  Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. , 1993, Journal of the National Cancer Institute.

[30]  S. Salmon,et al.  Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  C B Begg,et al.  Racial differences in the treatment of early-stage lung cancer. , 1999, The New England journal of medicine.

[32]  W. Curran,et al.  Race and prognosis of brain tumor patients entering multicenter clinical trials. A report from the Radiation Therapy Oncology Group. , 1996, American journal of clinical oncology.

[33]  W. Sause,et al.  The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). , 1992, International journal of radiation oncology, biology, physics.

[34]  K. Convery,et al.  Age‐race Interaction in Prostatic Adenocarcinoma Treated with External Beam Irradiation , 1993, American journal of clinical oncology.

[35]  J. Forman,et al.  The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostate. , 1998, Seminars in urologic oncology.

[36]  A. Huvos,et al.  Osteogenic sarcoma in the American black , 1983, Cancer.

[37]  B. Wójcik,et al.  Breast carcinoma survival analysis for african american and white women in an equal‐access health care system , 1998, Cancer.

[38]  C. Fuchs,et al.  Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. , 2001, Journal of the National Cancer Institute.

[39]  P. Grigsby,et al.  Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma. , 2000, Gynecologic oncology.

[40]  G. Samsa,et al.  Race, treatment, and survival among colorectal carcinoma patients in an equal‐access medical system , 1998, Cancer.

[41]  J. Eley,et al.  Racial Differences in Endometrial Cancer Survival: The Black/White Cancer Survival Study , 1996, Obstetrics and gynecology.

[42]  Paula R. Williamson,et al.  The value of the aggregate data approach in meta‐analysis with time‐to‐event outcomes , 2001 .

[43]  J. Cox,et al.  Breast cancer: Is ethnicity an independent prognostic factor for survival? , 1996, Cancer.

[44]  J. Carethers.  Racial and ethnic factors in the genetic pathogenesis of colorectal cancer. , 1999, Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians.

[45]  I. Thompson,et al.  Association of African-American ethnic background with survival in men with metastatic prostate cancer. , 2001, Journal of the National Cancer Institute.

[46]  N. Breen,et al.  The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study. , 1999, Ethnicity & disease.

[47]  D. Kuban,et al.  Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy. , 1995, Radiology.

[48]  K. Cummings,et al.  Delay, stage of disease, and survival among White and Black women with breast cancer. , 1983, American journal of public health.

[49]  R. Penchansky,et al.  Disaggregating the effects of race on breast cancer survival. , 1998, Family medicine.

[50]  B. Amendola,et al.  Radiation Therapy for Esophageal Cancer: The Medical College of Virginia Experience , 1980, Southern medical journal.

[51]  D. Wickerham,et al.  Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. , 1999, Journal of the National Cancer Institute.

[52]  David B. Pillemer,et al.  Summing Up: The Science of Reviewing Research , 1984 .

[53]  Hosmer,et al.  Medicare treatment differences for blacks and whites. , 1997, Medical care.

[54]  R. Hiatt,et al.  Comorbidity and breast cancer survival: a comparison between black and white women. , 1996, Annals of epidemiology.

[55]  S. Bigler,et al.  Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment. , 2000, The Journal of urology.

[56]  V. Shavers,et al.  Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.

[57]  B. Smedley,et al.  Unequal Treatment: Con-fronting Racial and Ethnic Disparities in Health Care , 2002 .

[58]  B. Hankey,et al.  A collaborative study of differences in the survival rates of black patients and white patients with cancer , 1992, Cancer.

[59]  Thomas E. Moritz,et al.  Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer. , 1993, Archives of internal medicine.

[60]  G. Kimmick,et al.  A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. The piedmont oncology association experience , 1991, Cancer.

[61]  M. Riggs,et al.  Stage at presentation and survival of white and black patients with prostate carcinoma , 1993, Cancer.

[62]  E. Struening,et al.  Race, poverty, and survival in multiple myeloma , 1984, Cancer.

[63]  B. Smedley,et al.  Evaluation of Priority Setting and Programs of Research on Ethnic Minority and Medically Underserved Populations at the National Institutes of Health , 1999 .

[64]  J. Krischer,et al.  Effects of health insurance and race on breast carcinoma treatments and outcomes , 2000, Cancer.

[65]  C. Redmond,et al.  Prognosis among African‐American women and white women with lymph node negative breast carcinoma , 1997, Cancer.

[66]  W. Satariano,et al.  The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer , 1994, Annals of Internal Medicine.

[67]  R. Weichselbaum,et al.  Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  M. Roach.  Is race an independent prognostic factor for survival from prostate cancer? , 1998, Journal of the National Medical Association.

[69]  V W Chen,et al.  Treatment plans for black and white women with stage II node‐positive breast cancer: The national cancer institute black/white cancer survival study experience , 1992, Cancer.

[70]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[71]  C. Redmond,et al.  Histological characteristics of breast carcinoma in blacks and whites. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[72]  Evans La.  Black and white differences: narrowing the gap in cancer medicine. , 1992 .

[73]  K D Kochanek,et al.  Deaths: final data for 1999. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[74]  P. Schellhammer,et al.  Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues , 1999, The Prostate.

[75]  N. Polissar,et al.  Social factors, treatment, and survival in early-stage non-small cell lung cancer. , 1998, American journal of public health.

[76]  N. Geller,et al.  Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists. , 1995, Controlled clinical trials.

[77]  J. Holland,et al.  Socioeconomic status and cancer survival. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  B. Kramer,et al.  Trends and black/white differences in treatment for nonmetastatic prostate cancer. , 1998, Medical care.

[79]  M. Roach,et al.  The prognostic significance of race and survival from breast cancer: a model for assessing the reliability of reported survival differences. , 1995, Journal of the National Medical Association.

[80]  D. Ansell,et al.  Race, income, and survival from breast cancer at two public hospitals , 1993, Cancer.

[81]  M. Roach,et al.  The prognostic significance of race and survival from laryngeal carcinoma. , 1992, Journal of the National Medical Association.

[82]  M. Morgan,et al.  Racial Differences in Survival From Gynecologic Cancer , 1996, Obstetrics and gynecology.

[83]  O. Brawley,et al.  Race and outcomes: is this the end of the beginning for minority health research? , 1999, Journal of the National Cancer Institute.

[84]  J. Fowler,et al.  Survival in blacks and whites after treatment for localized prostate cancer. , 1996, The Journal of urology.

[85]  B. Hankey,et al.  Factors associated with survival differences between black women and white women with cancer of the uterine corpus. , 1986, American journal of epidemiology.

[86]  H. Lai,et al.  Mortality in prostate cancer. , 1996, The Journal of urology.

[87]  G. Parham,et al.  Equal care ensures equal survival for African‐American women with cervical carcinoma , 2001, Cancer.

[88]  W. Reeves,et al.  Cervical cancer survival in a high risk urban population , 1995 .

[89]  Michael C. Minnotte,et al.  Noncancer deaths in white adult cancer patients. , 1993, Journal of the National Cancer Institute.

[90]  D. Berry,et al.  Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. , 1997, The cancer journal from Scientific American.

[91]  M. Bergner,et al.  Treatment Modality and Quality Differences for Black and White Breast-Cancer Patients Treated in Community Hospitals , 1989, Medical care.

[92]  U. Manne,et al.  Bcl‐2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas , 2000, International journal of cancer.

[93]  C. Lawton,et al.  Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms? , 1994, Radiology.

[94]  C K Redmond,et al.  Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. , 1994, JAMA.

[95]  H. Freeman.  The meaning of race in science‐‐considerations for cancer research , 1998, Cancer.

[96]  M. Shwartz.  Estimates of lead time and length bias in a breast cancer screening program , 1980, Cancer.